UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

147 Pharmacological characterization of NMS-P506, a novel second generation HSP90 inhibitor

European journal of cancer supplements, 2010, Vol.8 (7), p.52-52

2010

Volltextzugriff (PDF)

Inhibition of protein-protein interactions: The discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening

Proteins, structure, function, and bioinformatics, 2006-07, Vol.64 (1), p.60-67

2006

Volltextzugriff (PDF)

Potent and Selective Aurora Inhibitors Identified by the Expansion of a Novel Scaffold for Protein Kinase Inhibition

Journal of medicinal chemistry, 2005-04, Vol.48 (8), p.3080-3084

2005

Volltextzugriff (PDF)

Synthesis of dihydrolysergol analogues

Journal of heterocyclic chemistry, 2001-05, Vol.38 (3), p.759-763

2001

Volltextzugriff (PDF)

An Easy Entry to (1S, 2S) and (1R, 2R)-Threo-Ifenprodil

Synthetic communications, 2000-10, Vol.30 (19), p.3543-3553

2000

Volltextzugriff (PDF)

Disposition and urinary metabolic pattern of cabergoline, a potent dopaminergic agonist, in rat, monkey and man

Xenobiotica, 1993, Vol.23 (12), p.1377-1389

1993

Volltextzugriff (PDF)

FCE 23884, substrate-dependent interaction with the dopaminergic system. I. Preclinical behavioral studies

The Journal of pharmacology and experimental therapeutics, 1991-10, Vol.259 (1), p.345

1991

Volltextzugriff (PDF)

FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies

The Journal of pharmacology and experimental therapeutics, 1991-10, Vol.259 (1), p.356

1991

Volltextzugriff (PDF)

A new dopamine agonist in dopamine deprived systems: FCE 23884

Neurochemistry international, 1992-03, Vol.20 (MAR), p.179-183

1992

Volltextzugriff (PDF)

Caroxazone: a short-acting and reversible monoamine oxidase inhibitor with therapeutic potential for Parkinson's disease

European neuropsychopharmacology, 1991, Vol.1 (3), p.406-406

1991

Volltextzugriff (PDF)

Ergoline derivatives: receptor affinity and selectivity

Farmaco (Società chimica italiana : 1989), 1999-05, Vol.54 (5), p.288-296

1999

Volltextzugriff (PDF)

Total synthesis of the ionophore antibiotic CP-61,405 (routiennocin)

Tetrahedron, 1992, Vol.48 (37), p.7899-7938

1992

Volltextzugriff (PDF)

13-Tert-butylergoline derivatives. Assessment of functional serotonergic 5-HT1A component

Annals of the New York Academy of Sciences, 1997-05, Vol.812, p.226-228

1997

Volltextzugriff (PDF)

13‐Tert‐Butylergoline Derivatives: Assessment of Functional Serotonergic 5‐HT 1A Component

Annals of the New York Academy of Sciences, 1997-05, Vol.812 (1), p.226-228

1997

Volltextzugriff (PDF)

13-Tert-Butylergoline Derivatives

Annals of the New York Academy of Sciences, 1997-05, Vol.812 (1), p.226-228

1997

Volltextzugriff (PDF)

Serotonergic ergoline derivatives

Bioorganic & medicinal chemistry letters, 1998-05, Vol.8 (9), p.1117-1122

1998

Volltextzugriff (PDF)

D 1 Agonist and/or D 2 antagonist dopamine receptor properties of a series of ergoline derivatives: a structure–activity study

European journal of medicinal chemistry, 1999-02, Vol.34 (2), p.107-124

1999

Volltextzugriff (PDF)

Total Synthesis of the Carboxylic Acid Ionophore Antibiotic CP-61,405 (Routiennocin)

Synlett, 1992-05, Vol.1992 (5), p.395-399

1992

Volltextzugriff (PDF)

D1 agonist and/or D2 antagonist dopamine receptor properties of a series of ergoline derivatives : a structure-activity study

European journal of medicinal chemistry, 1999-02, Vol.34 (2), p.107-124

1999

Volltextzugriff (PDF)

Synthesis of 5(10Æ9)abeo-Ergolines

Heterocycles, 1997, Vol.45 (8), p.1493

1997

Volltextzugriff (PDF)

Synthesis and in vitro structure-activity relationship of 13-tert-butyl-ergoline derivatives as 5-HT1A receptor ligands

European journal of medicinal chemistry, 1997-10, Vol.32 (10), p.795-804

1997

Volltextzugriff (PDF)

Synthesis and in vitro structure-activity relationship of 13- tert-butyl-ergoline derivatives as 5-HT 1A receptor ligands

European journal of medicinal chemistry, 1997, Vol.32 (10), p.795-804

1997

Volltextzugriff (PDF)

(E) and (Z)-3-Styrylpiperidines as sigma ligands

Bioorganic & medicinal chemistry letters, 1997-06, Vol.7 (12), p.1525-1530

1997

Volltextzugriff (PDF)

Synthesis and nidation inhibitory activity of a new class of ergoline derivatives

European journal of medicinal chemistry, 1989, Vol.24 (4), p.421-426

1989

Volltextzugriff (PDF)

Diastereospecific formation of 6-N-oxide ergolines: a 1H NMR study of the configuration at nitrogen

Tetrahedron, 1992, Vol.48 (22), p.4555-4566

1992

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(45)
Animals
(27)
Humans
(25)
Male
(24)
Pharmacology & Pharmacy
(23)
Chemistry
(18)
Chemistry, Medicinal
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Rats
(17)
Mice
(16)
Female
(15)
Pharmacology. Drug Treatments
(14)
Physical Sciences
(13)
Alkaloids
(10)
Neuropharmacology
(10)
Chemistry, Organic
(9)
Ergolines - Pharmacology
(9)
Neurotransmitters. Neurotransmission. Receptors
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

147 Pharmacological characterization of NMS-P506, a novel second generation HSP90 inhibitor

Inhibition of protein-protein interactions: The discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening

Potent and Selective Aurora Inhibitors Identified by the Expansion of a Novel Scaffold for Protein Kinase Inhibition

Synthesis of dihydrolysergol analogues

An Easy Entry to (1S, 2S) and (1R, 2R)-Threo-Ifenprodil

Disposition and urinary metabolic pattern of cabergoline, a potent dopaminergic agonist, in rat, monkey and man

FCE 23884, substrate-dependent interaction with the dopaminergic system. I. Preclinical behavioral studies

FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies

A new dopamine agonist in dopamine deprived systems: FCE 23884

Caroxazone: a short-acting and reversible monoamine oxidase inhibitor with therapeutic potential for Parkinson's disease

Ergoline derivatives: receptor affinity and selectivity

Total synthesis of the ionophore antibiotic CP-61,405 (routiennocin)

13-Tert-butylergoline derivatives. Assessment of functional serotonergic 5-HT1A component

13‐Tert‐Butylergoline Derivatives: Assessment of Functional Serotonergic 5‐HT 1A Component

13-Tert-Butylergoline Derivatives

Serotonergic ergoline derivatives

D 1 Agonist and/or D 2 antagonist dopamine receptor properties of a series of ergoline derivatives: a structure–activity study

Total Synthesis of the Carboxylic Acid Ionophore Antibiotic CP-61,405 (Routiennocin)

D1 agonist and/or D2 antagonist dopamine receptor properties of a series of ergoline derivatives : a structure-activity study

Synthesis of 5(10Æ9)abeo-Ergolines

Synthesis and in vitro structure-activity relationship of 13-tert-butyl-ergoline derivatives as 5-HT1A receptor ligands

Synthesis and in vitro structure-activity relationship of 13- tert-butyl-ergoline derivatives as 5-HT 1A receptor ligands

(E) and (Z)-3-Styrylpiperidines as sigma ligands

Synthesis and nidation inhibitory activity of a new class of ergoline derivatives

Diastereospecific formation of 6-N-oxide ergolines: a 1H NMR study of the configuration at nitrogen

Suchergebnisse filtern